Agentix (AGTX) Total Current Liabilities (2014 - 2026)
Agentix's (AGTX) quarterly Total Current Liabilities came in at $3.6 million in Q1 2026, up 12.23% YoY from $3.2 million in Q1 2025, and up 2.62% on a QoQ basis from $3.5 million in Q4 2025.
Agentix (AGTX) Total Current Liabilities (2014 - 2026) Analysis & Trends
Agentix (AGTX) has 13 years of Total Current Liabilities data on file, last reported at $3.6 million in Q1 2026.
- Quarterly Total Current Liabilities rose 12.23% year-over-year to $3.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $3.6 million (up 12.23% YoY) and the FY2026 annual result came in at $3.6 million, up 12.23% from the prior year.
- Total Current Liabilities grew to $3.6 million in Q1 2026, from $3.5 million in the prior quarter.
- In the past five years, Total Current Liabilities ranged from a high of $3.6 million in Q1 2026 to a low of $1.0 million in Q1 2022.
- A 5-year average of $2.7 million and a median of $3.0 million in 2023 frame the typical range for Total Current Liabilities.
- Annual changes were most pronounced in 2022 — Total Current Liabilities soared 257.89% — and 2024, when it fell 4.52%.
- Tracing AGTX's Total Current Liabilities over 5 years: stood at $2.0 million in 2022, then surged by 49.8% to $3.0 million in 2023, then grew by 3.82% to $3.1 million in 2024, then grew by 14.12% to $3.5 million in 2025, then rose by 2.62% to $3.6 million in 2026.
- The last three Total Current Liabilities figures came in at $3.6 million (Q1 2026), $3.5 million (Q4 2025), and $3.4 million (Q3 2025), per Business Quant data.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Total Current Liabilities (Qtr) |
|---|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn | 3.94 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn | 5.53 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn | 1.58 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn | 2.53 Bn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn | 2.12 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn | 1.51 Bn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn | 2.49 Bn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn | 438.74 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - | 630.93 Mn |
| 10 | Agentix | 801,339.00 | 801,301.00 | - | 3.71 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 3.71 Mn |
| Mar 31, 2026 | 3.60 Mn |
| Dec 31, 2025 | 3.50 Mn |
| Sep 30, 2025 | 3.42 Mn |
| Jun 30, 2025 | 3.28 Mn |
| Mar 31, 2025 | 3.20 Mn |
| Dec 31, 2024 | 3.07 Mn |
| Sep 30, 2024 | 3.01 Mn |
| Jun 30, 2024 | 2.89 Mn |
| Mar 31, 2024 | 2.67 Mn |
| Dec 31, 2023 | 2.96 Mn |
| Sep 30, 2023 | 3.15 Mn |
| Jun 30, 2023 | 2.98 Mn |
| Mar 31, 2023 | 2.51 Mn |
| Dec 31, 2022 | 1.97 Mn |
| Sep 30, 2022 | 1.62 Mn |
| Jun 30, 2022 | 1.25 Mn |
| Feb 28, 2022 | 1.04 Mn |
| Nov 30, 2021 | 773,160.00 |
| Aug 31, 2021 | 606,942.00 |